Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,794 | 3,686 | 4,008 | 4,499 | 2,430 |
| Receivables | 572 | 780 | 979 | 1,034 | 479 |
| Inventories | 1,695 | 1,493 | 2,011 | 1,630 | 1,278 |
| TOTAL | $5,138 | $6,007 | $7,051 | $7,194 | $4,201 |
| Non-Current Assets | |||||
| PPE Net | 16 | 17 | 17 | 17 | 17 |
| Intangibles | 2,015 | 1,826 | 1,859 | 1,812 | 1,577 |
| TOTAL | $2,031 | $1,842 | $1,876 | $1,829 | $1,594 |
| Total Assets | $7,168 | $7,850 | $8,926 | $9,023 | $5,795 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 15 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 569 | 756 | 1,093 | 1,437 | 973 |
| Accrued Expenses | 867 | 134 | 134 | 128 | 607 |
| Other current liabilities | N/A | N/A | 2 | N/A | N/A |
| TOTAL | $1,451 | $891 | $1,228 | $1,565 | $1,581 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,365 | 3,740 | 3,683 | 3,416 | 3,242 |
| TOTAL | $3,365 | $3,740 | $3,683 | $3,416 | $3,242 |
| Total Liabilities | $4,816 | $4,630 | $4,912 | $4,981 | $4,823 |
| Shareholders' Equity | |||||
| Retained earnings | -21,072 | -20,718 | -20,190 | -18,999 | -17,691 |
| TOTAL | $2,352 | $3,219 | $4,015 | $4,042 | $972 |
| Total Liabilities And Equity | $7,168 | $7,850 | $8,926 | $9,023 | $5,795 |